Matt Outten Email & Phone Number
Chief Executive Officer at QED Therapeutics Oncology and Chief Commercial Officer at BridgeBio @ BridgeBio
5 free lookup(s).
If you need more lookups,
subscriptions start at $34 USD/month.
Matt Outten Location
- California, United States
Matt Outten Work
- Chief Executive Officer at QED Therapeutics Oncology and Chief Commercial Officer at BridgeBio @ (February 2019 - Present)
- Chief Commercial Officer @ QED Therapeutics, a BridgeBio Company (July 2018 - February 2019)
- Vice President of Marketing and Market Access @ (January 2015 - July 2018)
- Head of Market Access and Commercial Liaison @ (January 2014 - January 2015)
- Vice President Commercial Operations and Interim CCO @ (January 2014 - January 2014)
- Executive Director Market Access and Senior Director Market Access @ (January 2013 - January 2014)
- Director Managed Markets @ (June 2010 - February 2013)
- Associate Director of Reimbursement Strategy and National Accounts @ (July 2008 - June 2010)
- US Managed Markets Senior Product Manager - Virology, Oncology, CNS, and New Product Development @ (January 2007 - January 2008)
- US Managed Markets Product Manager Virology and Oncology @ (January 2006 - January 2007)
- US Marketing Product Manager Virology @ (January 2005 - January 2006)
- Virology Biologic Specialty Sales Representative @ (January 2004 - January 2005)
- Neurohealth Specialty Sales Representative @ (January 2002 - January 2004)
- Pharmaceutical Sales Representative and Field Trainer @ (January 2001 - January 2002)
Matt Outten Education
- Harvard University
Master of Liberal Arts in Extension Studies (Field: International Relations.)
- Hamilton College
BA (Psychology)
- University of Delaware
MBA (Management)
- The Hill School
Matt Outten Skills
- Biotechnology
- Budget Administration
- Cardiology
- Clinical Research
- Cross-functional Team Leadership
- Diabetes
- Due Diligence
- Gastroenterology
- Gross-to-Net Management
- Healthcare
- Hospitals
- In-Line / Payer Marketing Strategies
- Investor Relations
- Managed Care
- Market Access Strategy Development / Implementation
- Medical Devices
- Mergers & Acquisitions
- Neurology
- New Indication Launch
- Oncology
- Operations Management
- Organizational Leadership
- P&L Accountability
- Patient Assistance Program Creation
- Personnel Recruitment
- Pharmaceutical Industry
- Pharmaceutical Sales
- Pharmacoeconomic Modeling
- Pharmacy Benefit Management
- Pipeline Strategy Development
- Product Launch
- Rebate & Pricing Structuring / Negotiations
- Specialty Pharmacy / Distributor Network Formation
- Strategic Alliances / Co-Promotions
- Strategy
- Virology
- Leadership
- Co Promotions
- In Line
- Cross Functional Team
- Sales
- Rebate And Pricing Structuring
- Gross To Net Management
- Pharmacy Benefit
- Strategic Planning
- Operations
- Microsoft Office
- Distributor Network Formation
- Negotiations
- Marketing
- Payer Marketing Strategies
- Cross Functional Team Leadership
- Specialty Pharmacy
- Implementation
- Strategic Alliances
- Market Access
- Mergers and Acquisitions
- Organizational
- Market Access Strategy Development
- Change Management
Matt Outten Summary
- Matt Outten, based in California, United States, is currently a Chief Executive Officer at QED Therapeutics Oncology and Chief Commercial Officer at BridgeBio at BridgeBio. Matt Outten brings experience from previous roles at QED Therapeutics, a BridgeBio Company and Pharmacyclics. Matt Outten holds a Master of Liberal Arts in Extension Studies in Field: International Relations. @ Harvard University. With a robust skill set that includes Biotechnology, Budget Administration, Cardiology, Clinical Research, Cross-functional Team Leadership and more. Matt Outten has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Matt Outten?
Find contact details for 700 million professionals.
Others Named Matt Outten
Matt Outten
Co-Founder and CIO
Fort Wayne, IN, US
Matthew Outten
Training Specialist
Waynesville, MO, US
Top BridgeBio Employees
Clayton Beard
CSO and Site Head, Gene Therapy
Chapel Hill, NC, US
Markus Hauser
VP Patient Identification and Analytics
California, United States
Neil Kumar
CEO and Founder
California, United States
Rick Panicucci
Chief Technology Officer of CMC
Hilton Head Island, SC, US
Dunni Odumosu
Vice President, Regulatory Affairs Gene Therapy
Philadelphia, PA, US
Ted Lystig
SVP, Chief Analytics Officer
Huntsville, UT, US
Jim Tyson
Vice President, People
San Rafael, CA, US
Christine Siu
Chief Executive Officer, ML Bio Solutions
California, United States
Thomas Trimarchi
President and Chief Financial Officer
United States
Christine Zhang
Founder, Evanesco Therapeutics
California, United States
Sun-Gou Ji
Vice President, Computational Genomics
Boston, MA, US
Jesper Jernelius
Chief Technical Officer
San Francisco, CA, US
Steven Aronowitz
Chief People Officer
United States
Chinmay Shukla
Chief Business Officer
California, United States
Leonid Katz
Chief Development Officer, Cardiovascular
California, United States
Adam Castaño
Chief Medical Officer
New York, NY, US
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co